Why the study?
Does acetazolamide reduce the fall in serum K+ induced by glucose and insulin in patients with hypokalemic periodic paralysis?
Population
3 patients with hypokalemic periodic paralysis and normal persons
Comparison
Acetazolamide 250 mg four times daily vs Baseline and normal persons
Design
Case_series
Authors
Loading...
May support acetazolamide for K+ stabilization in hypokalemic periodic paralysis; leaves open effects on attack frequency.
Does acetazolamide reduce the fall in serum K+ induced by glucose and insulin in patients with hypokalemic periodic paralysis?
Acetazolamide ameliorates symptoms and reduces the pathological entry of potassium into muscle cells during attacks of hypokalemic periodic paralysis by inducing metabolic acidosis.
Frederic Q. Vroom (1975) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: